- Home
- ZNTL vs HRZN Comparison
ZNTL vs HRZN Comparison
Compare ZNTL & HRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ZNTL | HRZN |
|---|---|---|
| Founded | 2014 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 289.0M | 301.0M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | ZNTL | HRZN |
|---|---|---|
| Price | $4.49 | $4.73 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 5 |
| Target Price | ★ $6.60 | $6.50 |
| AVG Volume (30 Days) | ★ 1.2M | 752.8K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 33.85% |
| EPS Growth | ★ 18.03 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $12.25 |
| Revenue Next Year | N/A | $22.53 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.15 | $3.80 |
| 52 Week High | $6.95 | $8.46 |
Technical Indicators
Market Signals| Indicator | ZNTL | HRZN |
|---|---|---|
| Relative Strength Index (RSI) | 59.31 | 60.90 |
| Support Level | $3.53 | $3.96 |
| Resistance Level | $6.95 | $4.73 |
| Average True Range (ATR) | 0.38 | 0.15 |
| MACD | 0.10 | 0.04 |
| Stochastic Oscillator | 60.37 | 89.21 |
Price Performance
Historical ComparisonAbout ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
About HRZN Horizon Technology Finance Corporation
Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services, and sustainability industries.